KR910009715A - 요오드 함량이 높은 비이온성 x-선 조영제 - Google Patents

요오드 함량이 높은 비이온성 x-선 조영제 Download PDF

Info

Publication number
KR910009715A
KR910009715A KR1019900017792A KR900017792A KR910009715A KR 910009715 A KR910009715 A KR 910009715A KR 1019900017792 A KR1019900017792 A KR 1019900017792A KR 900017792 A KR900017792 A KR 900017792A KR 910009715 A KR910009715 A KR 910009715A
Authority
KR
South Korea
Prior art keywords
nonionic
ray contrast
dihydroxy
hydroxy
iodine content
Prior art date
Application number
KR1019900017792A
Other languages
English (en)
Inventor
스펙 울리히
블라츠키빅쯔 페터
Original Assignee
원본미기재
쉐링 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 쉐링 아크티엔게젤샤프트 filed Critical 원본미기재
Publication of KR910009715A publication Critical patent/KR910009715A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

요오드 함량이 높은 비이온성 X-선 조영제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 5-하이드록시아세트아미도-2,4,6-트리요오도-이소프탈산-(2,3-디하이드록시-N-메틸-프로필)-(2-하이드록시-에틸)-디아미드.
  2. 5-하이드록시아세트아미도-2,4,6-트리요오도-이소프탈산-(2,3-디하이드록시-N-메틸-프로필)-(2-하이드록시-에틸)-디아미드 및 약제학적으로 허용되는 담체을 포함하는 약제학적 조성물.
  3. 환자에게 5-하이드록시아세트아미도-2,4,6-트리요오도-이소프탈산-(2,3-디하이드록시-N-메틸-프로필)-(2-하이드록시-에틸)-디아미드를 투여함을 특징으로 하여, 환자의 X-선 영상에서의 조영을 향상시키는 방법.
  4. 제2항에 있어서, 요오드 50 내지 450mg/ml를 함유하는 조성물.
  5. 제4항에 있어서, 투여량이 2내지 500ml인 조성물.
  6. 제3항에 있어서, 혈관 X-선 촬영법인 방법.
  7. 제3항에 있어서, 요로조영술인 방법.
  8. 제3항에 있어서, 컴퓨터로 보조되는 단층사진술인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900017792A 1989-11-03 1990-11-03 요오드 함량이 높은 비이온성 x-선 조영제 KR910009715A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937118A DE3937118A1 (de) 1989-11-03 1989-11-03 Nichtionische roentgenkontrastmittel mit hohem jodgehalt
DE39371182 1989-11-03

Publications (1)

Publication Number Publication Date
KR910009715A true KR910009715A (ko) 1991-06-28

Family

ID=6393077

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900017792A KR910009715A (ko) 1989-11-03 1990-11-03 요오드 함량이 높은 비이온성 x-선 조영제

Country Status (17)

Country Link
US (1) US5183654A (ko)
EP (1) EP0426610B1 (ko)
JP (1) JP2807075B2 (ko)
KR (1) KR910009715A (ko)
AT (1) ATE109129T1 (ko)
AU (1) AU640177B2 (ko)
CA (1) CA2029194A1 (ko)
CZ (1) CZ277785B6 (ko)
DE (2) DE3937118A1 (ko)
DK (1) DK0426610T3 (ko)
ES (1) ES2058866T3 (ko)
FI (1) FI905419A0 (ko)
HU (1) HU208807B (ko)
IE (1) IE903953A1 (ko)
NO (1) NO904774L (ko)
PT (1) PT95770A (ko)
ZA (1) ZA908821B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0408654B1 (en) * 1988-04-06 1995-05-24 Mallinckrodt, Inc. Process for the preparation of 2,4,6-triiodo-5-amino-n-alkylisophthalamic acid
US5013865A (en) * 1988-04-06 1991-05-07 Mallinckrodt, Inc. Process for the preparation of 2,4,6-triiodo-5-amino-N-alkylisophthalamic acid and 2,4,6-triiodo-5-amino-isophthalamide compounds
US5611342A (en) * 1994-02-15 1997-03-18 Molecular Biosystems, Inc. Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
DE19510864A1 (de) * 1995-03-16 1996-09-19 Schering Ag Röntgenkontrastmittel für die Computertomographie und Urographie
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
DE10117242C1 (de) * 2001-04-06 2002-05-16 Schering Ag Unsymmetrische dimere Metallkomplexe, Liganden für diese Metallkomplexe, Verfahren zu deren Herstellung, Arzneimittel bzw. Diagnosemittel, die die Metallkomplexe enthalten, insbesondere Kontrastmittel
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
AU2009317450B2 (en) 2008-11-18 2015-05-07 Bracco Imaging Spa Process for the preparation of iodinated contrast agent
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608189A5 (ko) * 1974-12-13 1978-12-29 Savac Ag
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
CH626873A5 (ko) * 1977-03-28 1981-12-15 Bracco Ind Chimica Spa
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법

Also Published As

Publication number Publication date
US5183654A (en) 1993-02-02
CS540690A3 (en) 1992-11-18
CA2029194A1 (en) 1991-05-04
EP0426610A2 (de) 1991-05-08
HU208807B (en) 1994-01-28
JPH03173858A (ja) 1991-07-29
IE903953A1 (en) 1991-05-08
DE3937118A1 (de) 1991-05-08
DK0426610T3 (da) 1995-03-27
FI905419A0 (fi) 1990-11-01
PT95770A (pt) 1991-09-13
AU640177B2 (en) 1993-08-19
NO904774L (no) 1991-05-06
CZ277785B6 (en) 1993-04-14
ES2058866T3 (es) 1994-11-01
AU6578890A (en) 1991-05-09
ZA908821B (en) 1991-09-25
JP2807075B2 (ja) 1998-09-30
EP0426610A3 (en) 1991-09-25
HU907013D0 (en) 1991-05-28
ATE109129T1 (de) 1994-08-15
DE59006585D1 (de) 1994-09-08
NO904774D0 (no) 1990-11-02
EP0426610B1 (de) 1994-07-27
HUT57181A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
KR910009715A (ko) 요오드 함량이 높은 비이온성 x-선 조영제
RU2203653C2 (ru) Использование r-энантиомера n-пропаргил-1-аминоиндана, его солей и композиции, содержащие их
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR870005637A (ko) 약물 데포
ATE189400T1 (de) Knochenwachstumsfördernde zusammensetzung
HK1003978A1 (en) Composition for the treatment of schizophrenia
AR006510A1 (es) Un ligando quelante, un agente de contraste y una composicion para diagnostico por imagenes que los contiene
SE8700499D0 (sv) Novel pharmacologically active compounds
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
TW225536B (ko)
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
ES2103116T3 (es) Nuevos compuestos bi-aromaticos derivados de amida, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
ES2084585T3 (es) Derivados de la 6-oxo-piridazina, procedimiento para su obtencion y medicamentos que contienen estos compuestos.
KR900700102A (ko) 심장질환 치료에 쓰이는 프로파페논과 퀴니딘의 지속성 조성물
KR900017599A (ko) 종양 치료용 약학 조성물
GR3022773T3 (en) N?g -monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid